itolizumab
-
Coronavirus: Task force decides not to recommend Biocon’s itolizumab for treatment, say reports
Scroll Staff
-
Coronavirus: Biocon’s drug cleared after trial on just 30 patients, criticised for small sample size
Scroll Staff
-
Drug controller clears psoriasis injection for restricted emergency use on Covid-19 patients
Scroll Staff